l-Tryptophan as an antidepressive agent in the management of treatment-resistant unipolar depression in borderline personality disorder: Three case reports

Advances in Integrative Medicine - Tập 2 - Trang 68-71 - 2015
Stuart Richard Thomas1
1Consultant Psychiatrist, Melbourne, Australia.

Tài liệu tham khảo

Castle, 2009, STAR* D: has it taught us anything about the management of depression?, Australas Psychiatry, 17, 360, 10.1080/10398560903176958 Soloff, 2000, Characteristics of suicide attempts of patients with major depressive episode and borderline personality disorder: a comparative study, Am J Psychiatry, 157, 601, 10.1176/appi.ajp.157.4.601 Cascade, 2009, Real-world data on SSRI antidepressant side effects, Psychiatry (Edgmont), 6, 16 Zainuddin, 2012, Nutrition, adult hippocampal neurogenesis and mental health, Brit Med Bull, 103, 89, 10.1093/bmb/lds021 Iovieno, 2011, Second-tier natural antidepressants: review and critique, J Affect Disord, 130, 343, 10.1016/j.jad.2010.06.010 2012 Young, 1991, Use of tryptophan in combination with other antidepressant treatments: a review, J Psychiatry Neurosci, 16, 241 Gibson, 2014, Effects of acute treatment with a tryptophan-rich protein hydrolysate on plasma amino acids, mood and emotional functioning in older women, Psychopharmacology, 25 Kroes, 2014, Food can lift mood by affecting mood-regulating neurocircuits via a serotonergic mechanism, NeuroImage, 84, 825, 10.1016/j.neuroimage.2013.09.041 Hale, 1987, Clomipramine, tryptophan and lithium in combination for resistant endogenous depression: seven case studies, Brit J Psychiatry, 151, 213, 10.1192/bjp.151.2.213 Levitan, 2000, Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects, J Psychiatry Neurosci, 25, 337 Shaw, 2002, Tryptophan and 5-hydroxytryptophan for depression, Cochrane Database Syst Rev, 10.1002/14651858.CD003198 Beatson, 2010, Psychotherapy for borderline personality disorder Keitner, 2012, Management of treatment-resistant depression, Psychiatr Clin North Am, 35, 249, 10.1016/j.psc.2011.11.004 Dalton, 2000, Use of slow-release melatonin in treatment-resistant depression, J Psychiatry Neurosci, 25, 48 Bastien, 2008, Signs of insomnia in borderline personality disorder individuals, J Clin Sleep Med JCSM, 4, 462, 10.5664/jcsm.27283 Brodsky, 1997, Characteristics of borderline personality disorder associated with suicidal behavior, Am J Psychiatry, 154, 1715, 10.1176/ajp.154.12.1715 Amad, 2014, Genetics of borderline personality disorder: systematic review and proposal of an integrative model, Neurosci Biobehav Rev, 40, 6, 10.1016/j.neubiorev.2014.01.003 Ravindran, 2013, Complementary and alternative therapies as add-on to pharmacotherapy for mood and anxiety disorders: a systematic review, J Affect Disord, 150, 707, 10.1016/j.jad.2013.05.042 Database of Adverse Event Notifications – medicines [internet]. Therapeutic Goods Administration, Australian Government, Department of Health. 2013; [updated 19/6/2013; cited 7/10/2014]. Available from: http://www.tga.gov.au/safety/daen.htm#.VDO3y908aK1. Allen, 2011, Post-epidemic eosinophilia myalgia syndrome associated with l-tryptophan, Arthritis Rheum, 63, 3633, 10.1002/art.30514